Early detection of cancers using blood-based analytes for routine screening is a rapidly advancing area. Here, we developed a neural-network based solution to detect pancreatic ductal adenocarcinoma (PDAC) and non-small cell lung cancer (NSCLC) with high sensitivity and specificity using human plasma and serum samples to discriminate between subjects with no known pancreatic or lung disease, subjects with benign disease and subjects with PDAC or NSCLC.
How to access this content:
For one year after publication, abstracts and videos are only open to registrants of this annual meeting. Registrants should use their existing login information. Non-registrant access can be purchased via the ISMRM E-Library.
After one year, current ISMRM & ISMRT members get free access to both the abstracts and videos. Non-members and non-registrants must purchase access via the ISMRM E-Library.
After two years, the meeting proceedings (abstracts) are opened to the public and require no login information. Videos remain behind password for access by members, registrants and E-Library customers.
Keywords